metastasis

(redirected from Cancer of unknown primary)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Wikipedia.

metastasis

1. Pathol the spreading of a disease, esp cancer cells, from one part of the body to another
2. a rare word for metabolism

Metastasis

 

a secondary pathological focus arising from the transfer of a pathogenic principle (tumor cells, infectious agent) from the primary site of affection by the lymph or blood.

In the modern view, the term “metastasis” generally applies to the spread (dissemination) of malignant tumor cells; the spread of an infectious principle is usually described by the term “metastatic infectious focus.”

Benign tumors are also known to metastasize, and the capacity to do so is inherent in normal cells of various origin (in placental villi, adipose and hematopoietic bone-marrow cells). A distinctive feature of metastasizing tumor cells is the uncontrollable growth of the metastasis, relating it to primary foci of malignant growth. Metastatic tumor nodes retain other properties of primary tumors as well, such as microstructural features and the capacity to form the same products; however, metastatic nodes often have a more primitive structure and consist of functionally less mature cells than do the original tumors.

When tumor cells spread chiefly through the lymphatic vessels, metastases generally appear in the lymph nodes closest to the primary site. Although much research has been devoted to the routes and anatomical patterns of lymphogenous metastasis, the biological patterns of formation of lymphogenous metastases remain obscure. The mechanisms of hematogenous metastasis (to the lungs, liver, bones, and other viscera) are better understood. Four stages in the development of hematogenous metastasis are distinguished: (1) the detachment of cells from the primary tumor node and their penetration of the blood through the vascular wall; (2) the circulation of the tumor cells in the blood; (3) the attachment of the cells to the vascular wall and the start of intravascular growth; and (4) the rupture of the vascular wall by the tumorous masses and the subsequent growth of the metastasis into the tissue of the affected organ. The presence of metastasis indicates that a tumorous process has shifted from a local growth phase to a phase of generalization. A distinction is made between solitary metastasis, which generally can be removed surgically, and multiple metastases, which require combined treatment using radiation and chemotherapy.

N. S. KISELEVA

metastasis

[mə′tas·tə·səs]
(medicine)
Transfer of the causal agent (cell or microorganism) of a disease from a primary focus to a distant one through the blood or lymphatic vessels.
(physics)
A transition of an electron or nucleon from one bound state to another in an atom or molecule, or the capture of an electron by a nucleus.
References in periodicals archive ?
Cancer of unknown primary origin, or CUP, is among the 10 most common malignancies in the developed world, affecting about three to five percent of all cancer patients (1) (2) -- the equivalent of 30,000-50,000 new cases each year in the United States alone.
miRview(TM) mets is designed to accurately identify the primary tumor site in patients presenting with metastatic cancer, as well as in patients whose tumor has not been identified and consequently has been labeled Cancer of Unknown Primary (CUP).
This test is intended for Cancer of Unknown Primary patients, a case that represents around 5% of all the types of cancer and for which the diagnosis and therefore, adequate treatment, is extremely difficult by conventional techniques, resulting sometimes in high rates of toxic deaths caused by chemotherapy.
miRview[TM] mets - This test can accurately identify the primary tumor site in patients presenting with metastatic cancer, as well as in patients whose tumor has not been identified, and consequently been labeled Cancer of Unknown Primary (CUP).
There are an estimated 200,000 patients with uncertain primary tumors, including Cancer of Unknown Primary, in the U.
miRview[TM] mets - This test can accurately identify the primary tumor site in patients presenting with metastatic cancer, as well in patients whose tumor has not been identified, and consequently been labeled Cancer of Unknown Primary (CUP).
CupPrint(TM): Agendia's New Diagnostic Service for Identifying the Primary Tumor in Patients Diagnosed With Cancer of Unknown Primary (CUP)
Agendia was the first to commercialize a prognostic test - MammaPrint(R) - that predicts the chance of breast cancer recurrence and a diagnostic test - CupPrint(R)- to identify cancer of unknown Primary.

Full browser ?